New York State Common Retirement Fund lowered its stake in shares of MasTec, Inc. (NYSE:MTZ - Free Report) by 11.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 137,619 shares of the construction company's stock after selling 17,672 shares during the quarter. New York State Common Retirement Fund owned about 0.17% of MasTec worth $16,941,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. New York State Teachers Retirement System grew its position in shares of MasTec by 0.4% in the 3rd quarter. New York State Teachers Retirement System now owns 26,557 shares of the construction company's stock worth $3,269,000 after buying an additional 100 shares during the last quarter. Pallas Capital Advisors LLC boosted its stake in MasTec by 105.9% in the third quarter. Pallas Capital Advisors LLC now owns 7,175 shares of the construction company's stock valued at $879,000 after acquiring an additional 3,691 shares in the last quarter. Semanteon Capital Management LP purchased a new position in MasTec in the third quarter worth $877,000. Custom Index Systems LLC acquired a new position in shares of MasTec during the third quarter worth $458,000. Finally, State of Alaska Department of Revenue lifted its holdings in shares of MasTec by 7.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 7,013 shares of the construction company's stock valued at $863,000 after purchasing an additional 485 shares during the last quarter. Hedge funds and other institutional investors own 78.10% of the company's stock.
Insider Buying and Selling at MasTec
In related news, Director C Robert Campbell sold 3,000 shares of the stock in a transaction on Wednesday, September 18th. The shares were sold at an average price of $116.26, for a total transaction of $348,780.00. Following the sale, the director now directly owns 48,173 shares of the company's stock, valued at approximately $5,600,592.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other MasTec news, Director C Robert Campbell sold 3,000 shares of the company's stock in a transaction dated Wednesday, September 18th. The shares were sold at an average price of $116.26, for a total value of $348,780.00. Following the completion of the transaction, the director now owns 48,173 shares in the company, valued at approximately $5,600,592.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Robert E. Apple sold 19,023 shares of the firm's stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $135.63, for a total value of $2,580,089.49. Following the sale, the chief operating officer now owns 197,202 shares in the company, valued at $26,746,507.26. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,823 shares of company stock valued at $5,558,301. 21.30% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on MTZ shares. DA Davidson upped their target price on MasTec from $120.00 to $125.00 and gave the company a "buy" rating in a research report on Monday, August 5th. TD Cowen upped their price objective on shares of MasTec from $115.00 to $160.00 and gave the company a "buy" rating in a report on Monday. B. Riley reiterated a "buy" rating and issued a $166.00 target price (up from $151.00) on shares of MasTec in a research note on Tuesday. The Goldman Sachs Group upped their price target on shares of MasTec from $115.00 to $130.00 and gave the company a "neutral" rating in a research note on Wednesday, October 9th. Finally, Citigroup lifted their price objective on shares of MasTec from $122.00 to $150.00 and gave the stock a "buy" rating in a research note on Tuesday, October 22nd. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $148.62.
Check Out Our Latest Stock Report on MTZ
MasTec Stock Performance
Shares of NYSE MTZ traded up $4.09 during trading on Wednesday, reaching $140.63. 1,537,856 shares of the company traded hands, compared to its average volume of 856,182. MasTec, Inc. has a 12-month low of $46.70 and a 12-month high of $140.98. The company has a current ratio of 1.24, a quick ratio of 1.20 and a debt-to-equity ratio of 0.76. The stock has a market cap of $11.14 billion, a P/E ratio of 125.63 and a beta of 1.70. The firm's fifty day simple moving average is $120.16 and its 200 day simple moving average is $110.75.
MasTec Profile
(
Free Report)
MasTec, Inc, an infrastructure construction company, provides engineering, building, installation, maintenance, and upgrade services for communications, energy, utility, and other infrastructure primarily in the United States and Canada. It operates through five segments: Communications, Clean Energy and Infrastructure, Oil and Gas, Power Delivery, and Other.
See Also
Before you consider MasTec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MasTec wasn't on the list.
While MasTec currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.